Results 51 to 60 of about 1,139 (91)
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial. [PDF]
J Clin Oncol, 2016 Piccart-Gebhart M, Holmes E, Baselga J, de Azambuja E, Dueck AC, Viale G, Zujewski JA, Goldhirsch A, Armour A, Pritchard KI, McCullough AE, Dolci S, McFadden E, Holmes AP, Tonghua L, Eidtmann H, Dinh P, Di Cosimo S, Harbeck N, Tjulandin S, Im YH, Huang CS, Diéras V, Hillman DW, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Suter T, Gelber RD, Perez EA. +34 moreeuropepmc +1 more sourceGenomic diversity of uropathogenic Escherichia coli in clinical isolates from six latin american countries, 2018-2023. [PDF]
Rev Peru Med Exp Salud PublicaCaballero F, Martinez-Ventura A, Cuicapuza D, Fajardo-Loyola A, Gutierrez-Ajalcriña R, Soto-Pastrana J, Asmat-Marrufo P, Barco-Yaipen de Vera E, Meza-Fernandez H, Chambi-Quispe M, Pino-Dueñas J, Laura-Rivas N, Briones-Alejo A, Diaz-Rengifo P, Peralta-Siesquen C, Salvatierra G, Tsukayama P, Marcos-Carbajal P. +17 moreeuropepmc +1 more sourceMolecular detection of carbapenemases in critical microorganisms since the onset of the COVID-19 pandemic in Peru. [PDF]
JAC Antimicrob ResistMayta-Barrios M, Ramírez-Illescas J, Pacori J, Acosta J, Pampa-Espinoza L, Silva-Valencia J, Núñez-Llanos A, Bendezú C, Serrano K, Yagui-Moscoso M, Working group in the national surveillance of antimicrobial resistance . +10 moreeuropepmc +1 more source
